Synopsis:
Several fundamentally strong midcap players across jewellery, pharmaceuticals, consumer care, and engineering are trading at a discount of up to 40 percent from their 52-week highs.
When stocks trade at a discount, it often presents an attractive investment opportunity. Such a decline usually means that the stock is available at a cheaper valuation compared to its recent highs.
For long-term investors, this can be an ideal entry point if the company’s fundamentals remain strong, as they get the chance to buy quality businesses at a discount.
The stocks mentioned below are priced at over 30% lower than their 52-week high:
1. Kalyan Jewellers Limited
Kalyan Jewellers Limited designs, manufactures, and sells a wide variety of jewellery, including gold, studded, and other types, catering to different price ranges. Its collection covers everything from everyday wear to special occasion pieces, with wedding jewellery being its most popular segment.
With a market capitalization of Rs.51,116.52 crore, the shares of Kalyan Jewellers Limited closed at Rs.495.05, down by 2.02 percent from the previous day’s closing price of Rs.505.25. Currently, the company is trading at Rs.495.05 from its 52-week high of Rs. 794.60.
In the first quarter of FY25, the company’s revenue from operations was Rs.5,528 crore, and rose to Rs.7,268 crore in the same quarter of FY26. Net profit also rose to Rs.264 crore from Rs.178 crore for the same period. The firm’s return on equity stands at 16 percent, while return on capital employed stands at 15 percent. With a P/E ratio of 64.12 and an industry average of 28.82.
2. Cohance Lifesciences Limited
Cohance Lifesciences Limited, a Hyderabad-based CDMO that helps leading global pharmaceutical and chemical companies in developing new drugs. From initial research to large-scale manufacturing, we focus on delivering high-quality products that meet our clients’ requirements.
With a market capitalization of Rs.34,434.87 crore, the shares of Cohance Lifesciences closed at Rs.900.10, down by 0.18 percent from the previous day’s closing price of Rs.901.75. Currently, the company is trading at Rs.900.10 from its 52-week high of Rs.1,359.
In the first quarter of FY25, the company’s revenue from operations was Rs.488 crore, which rose to Rs.549 crore in the same quarter of FY26. Net profit slipped to Rs.46 crore from Rs.75 crore for the same period. The firm’s return on equity stands at 16 percent, while return on capital employed stands at 15 percent. With a P/E ratio of 66.10 and an industry average of 28.79.
Also Read: Smallcap stock jumps 6% after promoter releases 25 lakh pledged shares
3. Colgate Palmolive Limited
Colgate-Palmolive India Ltd makes and sells toothpaste, tooth powder, toothbrushes, mouthwash, and other personal care products. With a market capitalization of Rs.63,210.82 crore, the shares of Cohance Lifesciences closed at Rs.2,324.05, down by 0.83 percent from the previous day’s closing price of Rs.2,343.40. Currently, the company is trading at Rs.2,324.05 from its 52-week high of Rs.3,893.
In the first quarter of FY25, the company’s revenue from operations was Rs.1,497 crore, and slipped to Rs.1,434 crore in the same quarter of FY26. Net profit also slipped to Rs.321 crore from Rs.364 crore for the same period.
The firm’s return on equity stands at 81.2 percent, while return on capital employed stands at 105 percent. With a P/E ratio of 45.40 and an industry average of 52.50.
4. Thermax Limited
Thermax Limited provides solutions for the energy, environment, and chemical industries. Its offerings include boilers, heaters, chillers, power plants, solar equipment, pollution control systems, water and waste recycling plants, ion exchange resins, performance chemicals, and related services.
With a market capitalization of Rs.40,020.43 crore, the shares of Cohance Lifesciences closed at Rs.3,358.65, up by 2.65 percent from the previous day’s closing price of Rs.3,271.95. Currently, the company is trading at Rs.3,358.65 from its 52-week high of Rs.5,721.20.
In the first quarter of FY25, the company’s revenue from operations was Rs.2,184 crore, and slipped to Rs.2,150 crore in the same quarter of FY26. Net profit also rose to Rs.151 crore from Rs.109 crore for the same period.
The firm’s return on equity stands at 13.6 percent, while return on capital employed stands at 16.2 percent. With a P/E ratio of 59.58 and an industry average of 49.91.
Written By Jhanavi Sivakumar
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
